Total Payments
$232,164
2024 Payments
$617.85
Companies
31
Transactions
519
Medicare Patients
20,517
Medicare Billing
$1.3M
Payment Breakdown by Category
Other$204,439 (88.1%)
Consulting$11,085 (4.8%)
Food & Beverage$8,978 (3.9%)
Travel$7,315 (3.2%)
Education$347.67 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $204,439 | 73 | 88.1% |
| Consulting Fee | $11,085 | 8 | 4.8% |
| Food and Beverage | $8,978 | 366 | 3.9% |
| Travel and Lodging | $7,315 | 66 | 3.2% |
| Education | $347.67 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $89,543 | 124 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $54,073 | 49 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $50,554 | 87 | $0 (2022) |
| Amgen Inc. | $13,198 | 35 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $10,334 | 17 | $0 (2024) |
| Lilly USA, LLC | $10,184 | 12 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $628.85 | 16 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $608.24 | 48 | $0 (2024) |
| Boston Scientific Corporation | $469.80 | 30 | $0 (2024) |
| PFIZER INC. | $415.60 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $617.85 | 20 | AstraZeneca Pharmaceuticals LP ($138.09) |
| 2023 | $883.58 | 24 | AstraZeneca Pharmaceuticals LP ($342.94) |
| 2022 | $581.47 | 38 | Boston Scientific Corporation ($153.00) |
| 2021 | $354.89 | 22 | E.R. Squibb & Sons, L.L.C. ($118.63) |
| 2020 | $103.24 | 8 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($47.84) |
| 2019 | $25,597 | 71 | SANOFI-AVENTIS U.S. LLC ($9,282) |
| 2018 | $37,243 | 104 | SANOFI-AVENTIS U.S. LLC ($15,713) |
| 2017 | $166,783 | 232 | Novartis Pharmaceuticals Corporation ($81,090) |
All Payment Transactions
519 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.68 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $4.44 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/05/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: WATCHMAN_IC | ||||||
| 12/02/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: WATCHMAN_IC | ||||||
| 11/25/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.49 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/29/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: WATCHMAN_IC | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $3.47 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/31/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.14 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $3.62 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/04/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: WATCHMAN_IC | ||||||
| 07/02/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $3.57 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.53 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/28/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $124.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/12/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $121.13 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 01/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/23/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $123.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: WATCHMAN_IC | ||||||
| 11/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $129.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $125.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $10.12 | General |
| Category: WATCHMAN_IC | ||||||
| 09/29/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 4,730 | 6,202 | $629,355 | $238,122 |
| 2022 | 26 | 5,105 | 6,862 | $663,684 | $259,408 |
| 2021 | 25 | 5,459 | 7,705 | $713,356 | $300,458 |
| 2020 | 36 | 5,223 | 8,412 | $1.4M | $459,262 |
Total Patients
20,517
Total Services
29,181
Medicare Billing
$1.3M
Procedure Codes
134
All Medicare Procedures & Services
134 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 692 | 1,083 | $106,439 | $71,333 | 67.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 825 | 864 | $160,963 | $42,145 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 452 | 553 | $38,672 | $24,879 | 64.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 310 | 395 | $67,767 | $24,299 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 203 | $49,220 | $17,390 | 35.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 207 | 210 | $54,501 | $11,515 | 21.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 96 | 96 | $13,000 | $8,354 | 64.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 776 | 1,194 | $26,268 | $6,590 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $14,795 | $5,313 | 35.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 169 | 184 | $17,385 | $4,929 | 28.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 78 | 179 | $15,752 | $3,434 | 21.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $6,844 | $2,467 | 36.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 240 | 243 | $9,533 | $2,458 | 25.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 149 | 149 | $8,563 | $2,295 | 26.8% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Facility | 2023 | 19 | 121 | $9,196 | $2,129 | 23.1% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 102 | 103 | $6,739 | $1,780 | 26.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 13 | $1,768 | $1,252 | 70.8% |
| G0250 | Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Facility | 2023 | 19 | 175 | $3,845 | $1,155 | 30.0% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 46 | 50 | $3,750 | $952.56 | 25.4% |
| 93280 | Programming of dual lead pacemaker system | Facility | 2023 | 30 | 30 | $2,723 | $782.32 | 28.7% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 55 | 57 | $4,446 | $762.30 | 17.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 127 | 140 | $3,080 | $712.52 | 23.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 39 | 40 | $2,542 | $664.43 | 26.1% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2023 | 11 | 11 | $825.00 | $199.76 | 24.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 19 | 22 | $185.00 | $177.52 | 96.0% |
About Dr. Craig Stark, M.D
Dr. Craig Stark, M.D is a Cardiovascular Disease healthcare provider based in Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245212075.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Craig Stark, M.D has received a total of $232,164 in payments from pharmaceutical and medical device companies, with $617.85 received in 2024. These payments were reported across 519 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($204,439).
As a Medicare-enrolled provider, Stark has provided services to 20,517 Medicare beneficiaries, totaling 29,181 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 134 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Des Moines, IA
- Active Since 11/17/2005
- Last Updated 03/11/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1245212075
Products in Payments
- ENTRESTO (Drug) $89,312
- JARDIANCE (Drug) $60,351
- PRALUENT (Drug) $54,054
- Repatha (Biological) $13,029
- PRALUENT ALIROCUMAB INJECTION (Biological) $5,844
- PRALUENT (Biological) $4,491
- LifeVest (Device) $608.24
- WATCHMAN Access System (Device) $423.90
- XARELTO (Drug) $290.57
- Definity (Drug) $280.47
- ELIQUIS (Drug) $279.54
- BRILINTA (Drug) $243.85
- LEQVIO (Drug) $230.55
- PRADAXA (Drug) $192.54
- Corlanor (Drug) $168.47
- CHANTIX (Drug) $166.91
- FARXIGA (Drug) $158.89
- CAMZYOS (Drug) $143.98
- VYNDAQEL (Drug) $132.63
- ZONTIVITY (Drug) $124.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Des Moines
Atul Chawla, M.d, M.D
Cardiovascular Disease — Payments: $145,439
Cardiovascular Disease $145,439
David Mcallister, D.o, D.O
Cardiovascular Disease — Payments: $101,583
Cardiovascular Disease $101,583
William Wickemeyer, M.d, M.D
Cardiovascular Disease — Payments: $38,210
Cardiovascular Disease $38,210
Dr. Eduardo Antezano, M.d, M.D
Cardiovascular Disease — Payments: $10,839
Cardiovascular Disease $10,839
Mr. Shubha Deep Roy, M.d, M.D
Cardiovascular Disease — Payments: $8,771
Cardiovascular Disease $8,771
Marc Klein, M.d, M.D
Cardiovascular Disease — Payments: $6,522
Cardiovascular Disease $6,522